Further analysis through qRT-PCR on sodium bisulfite-converted DNA revealed no significant differences in methylation levels between stroke patients and healthy controls for the FV promoter region (Fig. 3B and Table 4), with only minimal variation observed in the FII promoter region (Fig. 3C and Table 5). This evidence concerns the gene F5 and Stroke.